UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia

Leukemia, 2014-01, Vol.28 (1), p.182-185

2014

Volltextzugriff (PDF)

Polymorphic Variation in TPMT Is the Principal Determinant of TPMT Phenotype: A Meta‐Analysis of Three Genome‐Wide Association Studies

Clinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.684-695

2017

Volltextzugriff (PDF)

Prognostic impact of IKZF1 deletions in association with vincristine–dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95

Leukemia, 2017-08, Vol.31 (8), p.1840-1842

2017

Volltextzugriff (PDF)

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Leukemia, 2010-02, Vol.24 (2), p.265-284

2010

Volltextzugriff (PDF)

Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact

European journal of medical genetics, 2016-03, Vol.59 (3), p.143-151

2016

Volltextzugriff (PDF)

P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE‐TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH‐RISK FIRST‐RELAPSE B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B‐ALL)

HemaSphere, 2022-06, Vol.6, p.259-260

2022

Volltextzugriff (PDF)

P305: COMPREHENSIVE TRANSCRIPTIONAL AND CYTOGENETIC PROFILING IMPROVES CLASSIFICATION AND DETECTION OF RISK‐STRATIFYING MARKERS IN THE B‐OTHER PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

HemaSphere, 2022-06, Vol.6, p.206-207

2022

Volltextzugriff (PDF)

Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95

Klinische Pädiatrie, 2005-11, Vol.217 (6), p.310-320

2005

Volltextzugriff (PDF)

Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000

Klinische Padiatrie, 2013-05, Vol.225 Suppl 1 (S 01), p.S62-S72

2013

Volltextzugriff (PDF)

Lineage Classification of Childhood Acute Lymphoblastic Leukemia according to the EGIL Recommendations: Results of the ALL-BFM 2000 Trial

Klinische Pädiatrie, 2013-05, Vol.225 (S 01), p.S8-S8

2013

Volltextzugriff (PDF)

Prediction of outcome by early response in childhood acute lymphoblastic leukemia

Klinische Padiatrie, 2013-05, Vol.225 Suppl 1, p.S50

2013

Volltextzugriff (PDF)

Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial

Klinische Padiatrie, 2014-11, Vol.226 (6-7), p.338-343

2014

Volltextzugriff (PDF)

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Haematologica (Roma), 2013-03, Vol.98 (3), p.428-432

2013

Volltextzugriff (PDF)

The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia

Leukemia, 2004-11, Vol.18 (11), p.1920-1923

2004

Volltextzugriff (PDF)

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

Journal of bone and mineral research, 2008-10, Vol.23 (10), p.1591-1600

2008

Volltextzugriff (PDF)

Advantages of a new taq DNA Polymerase in multiplex PCR and time-release PCR

BioTechniques, 1998, Vol.24 (1), p.154-158

1998

Volltextzugriff (PDF)

P1322 Environmental contamination in the rooms of MRSA-colonised patients

International journal of antimicrobial agents, 2007, Vol.29, p.S366-S366

2007

Volltextzugriff (PDF)

Over 15 years of ELTEC: A report of the international BFM study group

Pediatric Blood & Cancer, 2007-07, Vol.49 (1), p.113-114

2007

Volltextzugriff (PDF)

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

Osteoporosis international, 2011-06, Vol.22 (6), p.1935-1946

2011

Volltextzugriff (PDF)

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia

Leukemia, 2015-05, Vol.29 (5), p.1222-1222

2015

Volltextzugriff (PDF)

Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial AIEOP-BFM ALL 95

Klinische Pädiatrie, 2016, Vol.228 (3)

2016

Volltextzugriff (PDF)

Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects

European journal of clinical microbiology & infectious diseases, 1998-12, Vol.17 (11), p.754-760

1998

Volltextzugriff (PDF)

Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS

Current medical research and opinion, 2010-08, Vol.26 (8), p.1799-1807

2010

Volltextzugriff (PDF)

Erratum: ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia

Leukemia, 2015-05, Vol.29 (5), p.1222-1222

2015

Volltextzugriff (PDF)

TP53 single nucleotide variants (SNV) in patients developing second malignant neoplasms after treatment for childhood acute lymphoblastic leukemia

Klinische Pädiatrie, 2016, Vol.228 (3)

2016

Volltextzugriff (PDF)

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

Englisch
(211)
Deutsch
(29)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(122)
Humans
(116)
Female
(74)
Child
(69)
Male
(66)
Hematology
(63)
Child, Preschool
(52)
Infant
(48)
Oncology
(45)
Adolescent
(42)
Pediatrics
(38)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(36)
Acute Lymphoblastic Leukemia
(32)
Leukemia
(31)
Medicine
(29)
Medicine & Public Health
(29)
Biological And Medical Sciences
(26)
Prognosis
(25)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Genetics
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(45)
Leukemia
(18)
Haematologica
(14)
Zeitschrift Für Die Gesamte Innere Medizin Und Ihre Grenzgebiete
(12)
Journal Of Clinical Oncology
(7)
Klinische Pädiatrie
(7)
Bone
(6)
British Journal Of Haematology
(6)
Osteoporosis International
(6)
Hemasphere
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia

Polymorphic Variation in TPMT Is the Principal Determinant of TPMT Phenotype: A Meta‐Analysis of Three Genome‐Wide Association Studies

Prognostic impact of IKZF1 deletions in association with vincristine–dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact

P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE‐TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH‐RISK FIRST‐RELAPSE B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B‐ALL)

P305: COMPREHENSIVE TRANSCRIPTIONAL AND CYTOGENETIC PROFILING IMPROVES CLASSIFICATION AND DETECTION OF RISK‐STRATIFYING MARKERS IN THE B‐OTHER PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

Prognostic Impact of Age in Children and Adolescents with Acute Lymphoblastic Leukemia: Data from the Trials ALL-BFM 86, 90, and 95

Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000

Lineage Classification of Childhood Acute Lymphoblastic Leukemia according to the EGIL Recommendations: Results of the ALL-BFM 2000 Trial

Prediction of outcome by early response in childhood acute lymphoblastic leukemia

Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

Advantages of a new taq DNA Polymerase in multiplex PCR and time-release PCR

P1322 Environmental contamination in the rooms of MRSA-colonised patients

Over 15 years of ELTEC: A report of the international BFM study group

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia

Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial AIEOP-BFM ALL 95

Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects

Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS

Erratum: ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia

TP53 single nucleotide variants (SNV) in patients developing second malignant neoplasms after treatment for childhood acute lymphoblastic leukemia

Suchergebnisse filtern